Cutaneous iontophoresis of treprostinil in systemic sclerosis: A proof-of-concept study

Clinical Pharmacology and Therapeutics

Volumn 95, Issue 4, 2014, Pages 439-445

  Roustit, M ^a,b   Gaillard Bigot, F ^a   Blaise, S ^a,b   Stanke Labesque, F ^a,b   Cracowski, C ^b   Seinturier, C ^b   Jourdil, J F ^b   Imbert, B ^b   Carpentier, P H ^b   Cracowski, J L ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TREPROSTINIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEVELOPMENT; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HEMATOMA; HUMAN; IONTOPHORESIS; MALE; MIDDLE AGED; PETECHIA; PRIORITY JOURNAL; SKIN BLOOD FLOW; SYSTEMIC SCLEROSIS; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; AGED; ANTIHYPERTENSIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EPOPROSTENOL; FEASIBILITY STUDIES; FEMALE; FINGERS; HUMANS; IONTOPHORESIS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; SCLERODERMA, SYSTEMIC; SKIN; SKIN ULCER; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84897020993     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.255     Document Type: Article

References (22)

1. Gabrielli, A., Avvedimento, E.V. & Krieg, T. Scleroderma. N. Engl. J. Med. 360, 1989-2003 (2009.
2. Steen, V., Denton, C.P., Pope, J.E. & Matucci-Cerinic, M. Digital ulcers: Overt vascular disease in systemic sclerosis. Rheumatology (Oxford). 48 (suppl. 3), iii19-iii24 (2009.
3. Kowal-Bielecka, O. et al.; EUSTAR Co-Authors. EULAR recommendations for the treatment of systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann. Rheum. Dis. 68, 620-628 (2009.
4. Murray, A.K., Herrick, A.L., Gorodkin, R.E., Moore, T.L. & King, T.A. Possible therapeutic use of vasodilator iontophoresis. Microvasc. Res. 69, 89-94 (2005.
5. Murray, A.K., Moore, T.L., King, T.A & Herrick, A.L. Vasodilator iontophoresis a possible new therapy for digital ischaemia in systemic sclerosis? Rheumatology (Oxford). 47, 76-79 (2008.
6. Blaise, S., Roustit, M., Millet, C., Ribuot, C., Boutonnat, J. & Cracowski, J.L. Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats. Br. J. Pharmacol. 162, 557-565 (2011.
7. Roustit, M. et al. Iontophoresis of endothelin receptor antagonists in rats and men. PLoS ONE 7, e40792 (2012.
8. Blaise, S., Roustit, M., Hellmann, M., Millet, C. & Cracowski, J.L. Cathodal iontophoresis of treprostinil induces a sustained increase in cutaneous blood flux in healthy volunteers. J. Clin. Pharmacol. 53, 58-66 (2013.
9. Chung, L. & Fiorentino, D. A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis. J. Am. Acad. Dermatol. 54, 880-882 (2006.
10. Shah, A.A. et al. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: Pharmacokinetics and correlation with digital perfusion. Arthritis Res. Ther. 15, R54 (2013.
11. Roustit, M. & Cracowski, J.L. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharmacol. Sci. 34, 373-384 (2013.
12. Truchetet, M.E., Allanore, Y., Montanari, E., Chizzolini, C. & Brembilla, N.C. Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis. Ann. Rheum. Dis. 71, 2044-2050 (2012.
13. Roustit, M., Blaise, S. & Cracowski, J.L. Sodium nitroprusside iontophoresis on the finger pad does not consistently increase skin blood flow in healthy controls and patients with systemic sclerosis. Microvasc. Res. 77, 260-264 (2009.
14. Kalia, Y.N., Naik, A., Garrison, J. & Guy, R.H. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56, 619-658 (2004.
15. Roustit, M., Blaise, S. & Cracowski, J.L. Trials and tribulations of skin iontophoresis in therapeutics. Br. J. Clin. Pharmacol. (2013); e-pub ahead of print 16 April 2013.
16. Laliberte, K., Arneson, C., Jeffs, R., Hunt, T. & Wade, M. Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers. J. Cardiovasc. Pharmacol. 44, 209-214 (2004.
17. Ruaro, B., Sulli, A., Alessandri, E., Pizzorni, C., Ferrari, G. & Cutolo, M. Laser speckle contrast analysis: A new method to evaluate peripheral blood perfusion in systemic sclerosis patients. Ann. Rheum. Dis. (2013); e-pub ahead of print 16 August 2013.
18. Medsger, T.A. Jr et al. A disease severity scale for systemic sclerosis: Development and testing. J. Rheumatol. 26, 2159-2167 (1999.
19. Smith, V. et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann. Rheum. Dis. 71, 1636-1639 (2012.
20. LeRoy, E.C. & Medsger, T.A. Jr. Criteria for the classification of early systemic sclerosis. J. Rheumatol. 28, 1573-1576 (2001.
21. Roustit, M. & Cracowski, J.L. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharmacol. Sci. 34, 373-384 (2013.
22. Cutolo, M et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford). 43, 719-726 (2004.